IBER.WS
Ibere Pharmaceuticals Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share
IBER.WS
IBER.WS
Delisted
IBER.WS was delisted on the 15th of February, 2023.
30 hedge funds and large institutions have $3.74M invested in Ibere Pharmaceuticals Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share in 2021 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 0 closing their positions.
Holders
30
Holders Change
+9
Holders Change %
+42.86%
% of All Funds
0.46%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
10
Increased
3
Reduced
2
Closed
–
Calls
$2.22M
Puts
–
Net Calls
+$2.22M
Net Calls Change
-$21K
Top Buyers
Top Sellers
1 |
PAMP
1
Polar Asset Management Partners
Toronto,
Ontario, Canada
|
$80K |
2 |
2
Citadel Advisors
Miami,
Florida
|
$204K |